At the end of the latest market close, Acasti Pharma Inc. (ACST) was valued at $0.49. In that particular session, Stock kicked-off at the price of $0.4961 while reaching the peak value of $0.5278 and lowest value recorded on the day was $0.48. The stock current value is $0.47.
Recently in News on March 8, 2021, Acasti Pharma Provides Update on Recent Financing Activities. As required pursuant to the policies of the TSX Venture Exchange, Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) is providing an update on the use of its “at-the market” equity offering program. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Acasti Pharma Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.2200 on 02/10/21, with the lowest value was $0.3200 for the same time period, recorded on 01/04/21.
Acasti Pharma Inc. (ACST) full year performance was -19.18%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Acasti Pharma Inc. shares are logging -61.18% during the 52-week period from high price, and 176.96% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.17 and $1.22.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3778739 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Acasti Pharma Inc. (ACST) recorded performance in the market was 51.69%, having the revenues showcasing -24.44% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 98.66M, as it employees total of 32 workers.
Specialists analysis on Acasti Pharma Inc. (ACST)
During the last month, 0 analysts gave the Acasti Pharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.5992, with a change in the price was noted +0.1727. In a similar fashion, Acasti Pharma Inc. posted a movement of +57.38% for the period of last 100 days, recording 36,745,840 in trading volumes.
Trends and Technical analysis: Acasti Pharma Inc. (ACST)
Raw Stochastic average of Acasti Pharma Inc. in the period of last 50 days is set at 16.74%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 44.35%. In the last 20 days, the company’s Stochastic %K was 45.23% and its Stochastic %D was recorded 47.21%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 51.69%. Additionally, trading for the stock in the period of the last six months notably improved by 155.71%, alongside a downfall of -19.18% for the period of the last 12 months. The shares increased approximately by 5.91% in the 7-day charts and went up by -17.83% in the period of the last 30 days. Common stock shares were lifted by -24.44% during last recorded quarter.